COMMUNIQUÉS West-GlobeNewswire

CohBar Announces Approval for Listing on the NASDAQ Capital Market

13/12/2017 - 18:53

NASDAQ Trading to Begin on December 15, 2017 Under Existing Ticker Symbol CWBR MENLO PARK, Calif., Dec. 13, 2017 (GLOBE NEWSWIRE) -- CohBar, Inc. (OTCQX:CWBR) (TSXV:COB.U), an innovative biotechnology company focused on [...]

Tauriga Sciences, Inc. Fully Repays $80,000 USD 5% Face Value Convertible Debenture Issued to GS Capital Partners, LLC on June 27, 2017 for One Time Cash Payment of $108,164.38 USD

13/12/2017 - 18:51

NEW YORK, NY, Dec. 13, 2017 (GLOBE NEWSWIRE) -- Tauriga Sciences, Inc. (OTC PINK: TAUG ) ("Tauriga" or the "Company"), engaged in building business through the development, distribution, and licensing of proprietary [...]

Tyme to Present at Biotech Showcase™ 2018

13/12/2017 - 18:00

NEW YORK, Dec. 13, 2017 (GLOBE NEWSWIRE) -- Tyme Inc. (Nasdaq: TYME ), a clinical-stage biotechnology company developing cancer therapeutics, today announced that management will present a company overview at the [...]

CyberFuels Inc. announces distribution expansion throughout Canada and the USA

13/12/2017 - 17:15

PALM BEACH, Fla., Dec. 13, 2017 (GLOBE NEWSWIRE) -- EncounterCare Solutions (OTC:ECSL) announces that its subsidiary, CyberFuels Inc., is pleased to announce that it has signed a distribution contract with RLT Fuel [...]

Solera Health Expands Its Board of Directors with the Addition of Healthcare Industry Leader Mary Langowski

13/12/2017 - 16:00

PHOENIX, Dec. 13, 2017 (GLOBE NEWSWIRE) -- Solera Health today announced the appointment of healthcare industry veteran Mary Langowski as an independent director to the company’s board, effective immediately. Mary joins [...]

Ossur Hf : Financial calendar 2018

13/12/2017 - 15:41

Announcement no. 87/2017 Financial calendar 13 December 2017 Financial calendar 2018 Össur's financial calendar for 2018 Interim Report Q1 2018 25 April 2018 Interim Report Q2 2018 25 July 2018 Interim Report Q3 2018 24 [...]

Allakos Secures $100 Million In Series B Financing

13/12/2017 - 15:00

Proceeds will support advancement of AK002 in five disease areas Lead clinical program evaluating AK002 in eosinophilic gastroenteritis, an inflammatory gastrointestinal disease SAN CARLOS, Calif., Dec. 13, 2017 (GLOBE [...]

NSS Labs Announces Industry’s First Breach Prevention System Group Test Results

13/12/2017 - 15:00

AUSTIN, Texas, Dec. 13, 2017 (GLOBE NEWSWIRE) -- NSS Labs, Inc., a global leader and trusted source for independent fact-based cybersecurity guidance, today announced the results of its Breach Prevention Systems (BPS) [...]

Stemline Therapeutics Presents Detailed SL-401 Pivotal Data in BPDCN at ASH and Kicks Off its BPDCN Awareness Campaign; Updated Results From Ongoing Trials in Additional Malignancies Also Presented

13/12/2017 - 14:36

NEW YORK, Dec. 13, 2017 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq: STML ), a clinical-stage biopharmaceutical company developing novel therapeutics for difficult to treat cancers, presented detailed data [...]

Cascadian Therapeutics Added to the Nasdaq Biotechnology Index

13/12/2017 - 14:35

SEATTLE, Dec. 13, 2017 (GLOBE NEWSWIRE) -- Cascadian Therapeutics, Inc. (Nasdaq: CASC ), a clinical-stage biopharmaceutical company, today announced that it has been selected for addition to the Nasdaq Biotechnology [...]

Nuvectra Achieves 1,000th Algovita® SCS System Implantation in U.S.

13/12/2017 - 14:01

PLANO, Texas, Dec. 13, 2017 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR ), a neurostimulation medical device company, announced today that the company’s Algovita ® Spinal Cord Stimulation (SCS) system has now [...]

Amalgam Rx Partners with UCB on BEYOND™, a Digital Health Solution for Patients with Psoriasis and Psoriatic Arthritis

13/12/2017 - 14:00

WILMINGTON, Del., Dec. 13, 2017 (GLOBE NEWSWIRE) -- Allay Rx, a subsidiary of Amalgam Rx, Inc. , a leading digital therapeutics company, announced today a partnership on a comprehensive behavioral and patient support [...]

Women In Bio Holds First Annual Boardroom Ready Reception & Retreat for 2016/2017 Alumni in New York

13/12/2017 - 14:00

Application Process for the 2018 Boardroom Ready Program begins late December BOSTON, Dec. 13, 2017 (GLOBE NEWSWIRE) -- Women In Bio (WIB) an organization of professionals committed to promoting careers, leadership, and [...]

eTrueNorth Expands its eLabNetwork™ Platform Internationally

13/12/2017 - 14:00

DALLAS, Dec. 13, 2017 (GLOBE NEWSWIRE) -- e TrueNorth, the U.S.-based healthcare technology solution provider for CLIA-waived laboratories, announced today that it has grown its business internationally with a new [...]

Xbrane Biopharma informs about changes in management team

13/12/2017 - 13:31

Pressrelease 2017-12-13 Xbrane Biopharma AB ("Xbrane" or "the Company") announces that Carlo Colombo, Head of Production within Xbranes long acting injectable business, who forms a part of Xbranes management team, has [...]

Nephros Receives $1.8 Million in Cash from Sale of Tax Credits

13/12/2017 - 13:30

SOUTH ORANGE, NJ, Dec. 13, 2017 (GLOBE NEWSWIRE) -- Nephros, Inc. (OTCQB: NEPH) a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid- [...]

Marinus Pharmaceuticals Added to NASDAQ Biotechnology Index

13/12/2017 - 13:30

RADNOR, Pa., Dec. 13, 2017 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS ) (the “Company”), a biopharmaceutical company dedicated to the development of innovative therapeutics to treat epilepsy and [...]

Strongbridge Biopharma plc Added to the NASDAQ Biotech Index

13/12/2017 - 13:30

DUBLIN, Ireland and TREVOSE, Pa., Dec. 13, 2017 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc, (Nasdaq: SBBP ), a global commercial-stage biopharmaceutical company focused on the development and commercialization of [...]

Iovance Biotherapeutics Announces Manufacturing Decision, Provides Clinical Updates and Highlights Pipeline Expansion at Analyst Day 2017

13/12/2017 - 13:05

- Generation 2 Manufacturing Process Selected for All Ongoing and Future TIL Clinical Development - - Company Reports Updated Results for Cohort 2 in Melanoma Study - - Two New Studies in NSCLC Patients in Collaboration [...]